GlassScriptPhysician profile
Brad Alan Bowyer
NPI 1205821089
$421.61
in general payments reported to CMS, 2019-2025
9 companies · $15.42 in 2025
The $15.42 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.00 · 2020: $117 · 2021: $26.52 · 2022: $117 · 2024: $108 · 2025: $15.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $133.63 | 2020-2022 | |
| Enterra Medical, INC. | $107.63 | 2024 | |
| Pfizer INC. | $44.13 | 2019-2020 | |
| Abbvie INC. | $38.62 | 2022 | |
| Janssen Biotech, INC. | $30.83 | 2022 | |
| Janssen Scientific Affairs, LLC | $20.06 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.67 | 2019 | |
| Ucb, INC. | $15.62 | 2020 | |
| Olympus America INC. | $15.42 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Bowyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.